Trexquant Investment LP Oncorus, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.44 - $5.62 $33,503 - $130,754	-23,266 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.03 - $11.63 $13,892 - $32,122	-2,762 Reduced 10.61%	23,266 $123,000
Q3 2021 Nov 12, 2021	BUY	$9.29 - $14.27 $110,727 - $170,084	11,919 Added 84.48%	26,028 $243,000
Q2 2021 Aug 12, 2021	BUY	$13.3 - $17.3 $187,649 - $244,085	14,109 New	14,109 $195,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.